Literature DB >> 14099998

THE URINARY EXCRETION AND TISSUE RETENTION OF CYANOCOBALAMIN BY SUBJECTS GIVEN REPEATED PARENTERAL DOSES.

J F ADAMS.   

Abstract

The urinary excretion of injected cyanocobalamin was studied in 30 previously untreated vitamin B(12)-deficient patients by measuring the urinary radioactivity after repeated injections of (58)Co vitamin B(12). The dose range used was 54 to 30,000 mug., each patient receiving the same dose at each injection. The results show that there is no constant trend to the excretion of greater or smaller proportions of the amount injected. It is also shown that there is a wide variation in the amounts excreted by each individual and between individual patients and that the capacity of the tissues to retain injected cyanocobalamin is very great, the amounts retained often being greatly in excess of the normal body stores. The excretion of radioactivity after parenteral infections of (58)Co vitamin B(12) was usually complete within 24 hours but exceptions to this were seen. The significance and value of the results is discussed.

Entities:  

Keywords:  ANEMIA, MACROCYTIC; ANEMIA, PERNICIOUS; COBALT ISOTOPES; INJECTIONS, INTRAVENOUS; URINE; VITAMIN B 12

Mesh:

Substances:

Year:  1964        PMID: 14099998      PMCID: PMC480666          DOI: 10.1136/jcp.17.1.31

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Microbiological methods of assay in clinical medicine with particular reference to the investigation of deficiency of vitamin B12 and folic acid.

Authors:  R H GIRDWOOD
Journal:  Scott Med J       Date:  1960-01       Impact factor: 0.729

2.  Total serum vitamin B12 concentration in normal human adult serum assayed by Euglena gracilis.

Authors:  N K SHINTON
Journal:  Clin Sci       Date:  1959-08       Impact factor: 6.124

3.  Gastrointestinal absorption and urinary excretion of vitamin B12-Co60.

Authors:  L D MACLEAN; H S BLOCH
Journal:  Proc Soc Exp Biol Med       Date:  1954-10

4.  The application of vitamin B12 tolerance tests to American and Mexican subjects.

Authors:  S C ESTRADA; C A LANG; B F CHOW
Journal:  J Lab Clin Med       Date:  1954-03

5.  Intrinsic factor studies II. The effect of gastric juice on the urinary excretion of radioactivity after the oral administration of radioactive vitamin B12.

Authors:  R F SCHILLING
Journal:  J Lab Clin Med       Date:  1953-12

6.  Storage and elimination of vitamin B12 in the rat.

Authors:  R A HARTE; B F CHOW; L BARROWS
Journal:  J Nutr       Date:  1953-04       Impact factor: 4.798

7.  Urinary excretion of vitamin B12.

Authors:  M F SOKOLOFF; E H SANNEMAN; M F BEARD
Journal:  Blood       Date:  1952-02       Impact factor: 22.113

8.  A simplified silver iodate method for the determination of chloride.

Authors:  E J KING; D S BAIN
Journal:  Biochem J       Date:  1951-01       Impact factor: 3.857

9.  Oral administration of vitamin B12 containing cobalt60 to rats.

Authors:  B F CHOW; C ROSENBLUM; R H SILBER; D T WOODBURY; R YAMAMOTO; C A LAND
Journal:  Proc Soc Exp Biol Med       Date:  1951-02

10.  Radioactive penicillin and vitamin B12.

Authors:  E L SMITH
Journal:  Br Med Bull       Date:  1952       Impact factor: 4.291

View more
  3 in total

1.  Vitamin B12 and Plant-Predominant Diets.

Authors:  Nicole D White
Journal:  Am J Lifestyle Med       Date:  2022-05-04

Review 2.  Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency.

Authors:  Rima Obeid; Sergey N Fedosov; Ebba Nexo
Journal:  Mol Nutr Food Res       Date:  2015-05-12       Impact factor: 5.914

Review 3.  Vitamin B12 among Vegetarians: Status, Assessment and Supplementation.

Authors:  Gianluca Rizzo; Antonio Simone Laganà; Agnese Maria Chiara Rapisarda; Gioacchina Maria Grazia La Ferrera; Massimo Buscema; Paola Rossetti; Angela Nigro; Vincenzo Muscia; Gaetano Valenti; Fabrizio Sapia; Giuseppe Sarpietro; Micol Zigarelli; Salvatore Giovanni Vitale
Journal:  Nutrients       Date:  2016-11-29       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.